EWA
HZNP

EverSource Wealth Advisors’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

EverSource Wealth Advisors’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,021
Closed -$118K – 2788
2023
Q3 		$118K Buy
1,021
+34
+3% +$3.65K 0.01% 513
2023
Q2 		$102K Sell
987
-224
-18% -$23.6K 0.01% 578
2023
Q1 		$132K Buy
1,211
+12
+1% +$1.33K 0.02% 462
2022
Q4 		$136K Buy
1,199
+408
+52% +$33.9K 0.02% 429
2022
Q3 		$49K Sell
791
-133
-14% -$9.29K 0.01% 645
2022
Q2 		$73K Buy
924
+45
+5% +$4.26K 0.02% 483
2022
Q1 		$92K Buy
879
+274
+45% +$26.7K 0.02% 348
2021
Q4 		$65K Buy
+605
New +$66K 0.02% 375

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $247M AUM 21.93% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.05B AUM 19.75% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

EverSource Wealth Advisors's HZNP Position: Q4 2023 in Review

EverSource Wealth Advisors sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 1,021 shares — an estimated $118K sold.

EverSource Wealth Advisors first reported a position in HZNP in Q4 2021 and held it in 8 quarters. The position peaked at $136K in Q4 2022. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • EverSource Wealth Advisors reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • EverSource Wealth Advisors sold 1,021 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $118K.
  • EverSource Wealth Advisors first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2021 and held it in 8 quarters.
  • EverSource Wealth Advisors's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $136K in Q4 2022.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on EverSource Wealth Advisors's 13F filing for Q4 2023, filed 9 Feb 2024.